ACAS LLC’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$214K Buy
+1,225
New +$188K 0.14% 86
2025
Q1
Sell
-1,383
Closed -$214K 87
2024
Q4
$214K Sell
1,383
-100
-7% -$15.5K 0.16% 85
2024
Q3
$240K Hold
1,483
0.2% 75
2024
Q2
$234K Sell
1,483
-20
-1% -$2.97K 0.2% 74
2024
Q1
$238K Sell
1,503
-309
-17% -$49.2K 0.23% 70
2023
Q4
$284K Sell
1,812
-100
-5% -$15.3K 0.32% 59
2023
Q3
$298K Buy
1,912
+1
+0.1% +$165 0.37% 54
2023
Q2
$316K Sell
1,911
-77
-4% -$12.4K 0.43% 51
2023
Q1
$308K Sell
1,988
-72
-3% -$11.6K 0.44% 50
2022
Q4
$364K Buy
+2,060
New +$356K 0.56% 43
2022
Q2
$356K Buy
2,040
+51
+3% +$9.09K 0.53% 43
2022
Q1
$352K Sell
1,989
-29
-1% -$4.93K 0.48% 45
2021
Q4
$345K Sell
2,018
-134
-6% -$21.9K 0.44% 48
2021
Q3
$348K Hold
2,152
0.48% 47
2021
Q2
$355K Sell
2,152
-35
-2% -$5.79K 0.5% 47
2021
Q1
$359K Buy
+2,187
New +$354K 0.56% 45

Other funds holding JNJ

ACAS LLC's JNJ Position: Q2 2025 in Review

ACAS LLC opened a new position in Johnson & Johnson (JNJ) in Q2 2025: 1,225 shares worth $214K. The stake represents 0.14% of the portfolio and ranks #86 among its holdings. This is a return to the name: ACAS LLC previously reported a position in JNJ as recently as Q4 2024.

ACAS LLC first reported a position in JNJ in Q1 2021 and has held it in 16 quarters since. The position peaked at $364K in Q4 2022. 4,082 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • ACAS LLC held 1,225 shares of Johnson & Johnson worth $214K as of Q2 2025.
  • Johnson & Johnson was a new ACAS LLC position in Q2 2025.
  • Johnson & Johnson made up 0.14% of ACAS LLC's portfolio in Q2 2025, its #86 holding.
  • ACAS LLC first reported a position in Johnson & Johnson in Q1 2021 and has held it in 16 quarters since.
  • ACAS LLC's Johnson & Johnson position peaked at $364K in Q4 2022.
  • 4,082 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on ACAS LLC's 13F filing for Q2 2025, filed 14 Aug 2025.